US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

13.220
-0.580-4.20%

Trading Dec 13 09:58 ET

340.78MMarket Cap-11.77P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Contineum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

Contineum Therapeutics Earnings Reports

Contineum Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:16 ET

Contineum Therapeutics | 8-K: Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 6 16:14 ET

Contineum Therapeutics | 10-Q: Quarterly report

Aug 14 12:50 ET

Contineum Therapeutics | 8-K/A: Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 14 12:25 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall